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Inter-individual differences in gene expression are likely to account for an important fraction of phenotypic
differences, including susceptibility to common disorders. Recent studies have shown extensive variation
in gene expression levels in humans and other organisms, and that a fraction of this variation is under
genetic control. We investigated the patterns of gene expression variation in a 25 Mb region of human
chromosome 21, which has been associated with many Down syndrome (DS) phenotypes. Taqman real-
time PCR was used to measure expression variation of 41 genes in lymphoblastoid cells of 40 unrelated
individuals. For 25 genes found to be differentially expressed, additional analysis was performed in 10
CEPH families to determine heritabilities and map loci harboring regulatory variation. Seventy-six percent
of the differentially expressed genes had significant heritabilities, and genomewide linkage analysis led to
the identification of significant eQTLs for nine genes. Most eQTLs were in trans, with the best result
(P 5 7.46 3 1028) obtained for TMEM1 on chromosome 12q24.33. A cis-eQTL identified for CCT8 was
validated by performing an association study in 60 individuals from the HapMap project. SNP rs965951
located within CCT8 was found to be significantly associated with its expression levels (P 5 2.5 3 1025)
confirming cis-regulatory variation. The results of our study provide a representative view of expression
variation of chromosome 21 genes, identify loci involved in their regulation and suggest that genes, for
which expression differences are significantly larger than 1.5-fold in control samples, are unlikely to be
involved in DS-phenotypes present in all affected individuals.
INTRODUCTION
Understanding the relationship between sequence variation
present in human populations (1) and phenotypic diversity is
one of the main challenges of functional genomics. Only a
fraction of polymorphic variation is likely to be of functional
significance, and traditionally, studies have focused on
polymorphisms that alter the primary sequence of proteins
as prime candidates for functional variation (qualitative
changes). Early studies in model organisms as well as in
humans have shown that functional protein sequence variants
or hypomorphs are indeed a valid paradigm to explain trait
# The Author 2005. Published by Oxford University Press. All rights reserved.
For Permissions, please email: journals.permissions@oxfordjournals.org
{
These authors equally contributed to this study.
{{Present address: EPAM, Norwegian Institute of Public Health, Oslo, Norway.
*To whom correspondence should be addressed. Tel: þ41 223795708; Fax: þ41 223795706; Email: stylianos.antonarakis@medecine.unige.ch
Human Molecular Genetics, 2005, Vol. 14, No. 23 3741–3749
doi:10.1093/hmg/ddi404
Advance Access published on October 26, 2005
differences within populations (2–4). Interestingly, however,
numerous recent association studies implicating genetic
variation of a gene to a particular phenotype have failed to
identify coding SNPs as candidates for the etiological effect,
suggesting that other mechanisms are likely to underlie the
molecular pathology in these disorders (5–7).
An alternative way in which sequence variation can have a
functional impact is by affecting the steady-state level of
mRNA molecules of a particular gene in a given cell (quanti-
tative changes). Since the 1970s, it has been suggested that
quantitative differences in gene expression might provide a
significant source of variation in natural populations, repre-
senting an important substrate for evolution and accounting
for a considerable fraction of phenotypic diversity (8).
Changes in the dosage of a gene or group of genes have
previously been shown to be associated with human disorders
such as trisomy 21 and other contiguous gene syndromes
(9–12). It is thus likely that differences in gene expression
can also explain the population variance of many traits.
High-throughput expression profiling in a number of organ-
isms has revealed that variation in gene expression levels
within and among populations is abundant, with a large pro-
portion of genes (20–40% in most studies) showing significant
patterns of inter-individual variation (13–16). Although
this variation could be of stochastic, environmental or
genetic origin, analyses of expression differences in segregat-
ing populations (from lower eukaryotes to mammals) have
demonstrated that a significant proportion of the variance
has a genetic component (16–19). As such, gene expression
levels can be considered as a quantitative trait (eQTL) and
thus be dissected using standard genetic approaches such as
quantitative linkage analysis.
Understanding the pattern of gene expression variation in
humans is important, as it is likely to underlie a significant
proportion of the risk for many common disorders. In the
context of human chromosome 21 (Hsa21), this question is
particularly relevant because it could help to understand the
relationship between trisomy of Hsa21 and Down syndrome
(DS) phenotypes and, in particular, give new insights into
the molecular basis of the extensive phenotypic heterogeneity
observed in trisomy 21 patients (20).
In our study, we set out to investigate the patterns of gene
expression variation in a 25 Mb region of Hsa21, using a
high-precision approach combining TaqMan real-time PCR
and multiple replicates per sample.
We screened for inter-individual differences in expression
in 41 genes using a panel of lymphoblastoid cell lines
derived from 40 unrelated individuals from the CEPH collec-
tion (21). Genes found to be differentially expressed were
further analyzed in 10 three-generation families in order to
determine: (i) What fraction of the variation has a genetic
component? (ii) Which loci in the genome are associated
with these expression traits?
RESULTS
Gene expression variation
Out of 71 Taqman assays initially designed, a total of 41 met
our efficiency criteria of 0.95 , E , 1.05 (10) in RNAs from
lymphoblastoid cell lines. These 41 genes were screened for
differential gene expression in cDNAs obtained from 40
unrelated individuals, namely the grandparents of 10 CEPH
families (Fig. 1). For each individual, we calculated the
normalized relative expression for each of the 41 genes as
described in Methods section. The median 95% CIs for rela-
tive expression measurements was +0.18, indicating that
inter-individual differences as small as 1.4-fold could be
readily detected for the large majority of assays.
To exclude Epstein–Barr virus (EBV) transformation effects
and cell culture conditions as major sources of gene expression
variation, we transformed lymphocytes from the same individ-
ual six independent times over a 2-week period. Expression
analysis of 25 HSA21 genes and seven normalization genes
in these cell lines showed high-expression correlations for all
genes, and inter- and intra-cell line variation were not signifi-
cantly different (R. Lyle and A. Reymond, unpublished data).
To determine which genes were differentially expressed
between individuals, we used the variance ratio (15), which
gives the ratio of the inter-individual variance over the
average intra-individual error. Twenty-five genes were selected
for further study based on having a variance ratio .1 (Table 1).
The median fold change in expression (ratio of individual
with highest expression over individual with lowest
expression) for the set of differentially expressed genes was
3.2, but values ranged from 2 to 47.43 (Table 1). However,
for some genes (e.g. APP and CBS) in which a number of indi-
viduals display very low expression levels, the fold change
might be overestimated due to limitations in the sensitivity
of detection.
Heritability
To determine what fraction of the variance of the differentially
expressed genes could be attributed to genetic components, we
measured expression levels in 10 three-generation families
from the CEPH collection (21). In total, we assayed cDNAs
from 135 individuals, including the initial 40 unrelated indi-
viduals who are the grandparents of these pedigrees.
Seventeen out of the 25 differentially expressed genes had
significant heritability values (P , 0.05), with a maximum
of 0.84 observed for SLC37A1 (P ¼ 8.07  10211) and a
median of 0.42 for all genes (Fig. 2).
We also calculated the significance of the heritability esti-
mates for each trait by multiple permutation analysis. For
this purpose, we permuted the phenotype (normalized relative
expression level) for each gene 500 times and calculated the
heritability using the same family structures. Results from
this calculation showed that all 17 genes previously found to
have significant heritabilities remained significant, and in
addition, two of the genes that had been considered marginally
not significant (INFAR2 and PRDM15 both at P ¼ 0.06) were
significant at the 95% level by multiple permutation and were
thus considered for quantitative linkage analysis.
eQTL mapping
To identify candidate loci involved in the transcriptional
control of chromosome 21 genes, we performed genomewide
quantitative linkage analysis on the 10 study families. We used
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SNP genotyping information available in public databases. All
genotyping errors as assessed by Mendelian incompatibility
patterns were removed (22).
For our pedigrees, we estimated 60% power to detect a
suggestive (P , 0.001) eQTL given the median heritability
of 0.42. This power increases to .90% for heritability
values over 0.6.
Multipoint linkage analysis resulted in the identification of
at least one eQTL for four genes (first four genes) (Table 2)
using a threshold of P , 1.6  1024 (which corresponds to
the theoretical genomewide significance of 0.05) (23). The
most significant result was obtained for TMEM1 with
P ¼ 7.46  1028 (LOD score of 6). In one case, the eQTL
for a gene (CCT8) mapped to within 5 Mb of its physical
location (cis-eQTL), whereas the other eQTLs were located
elsewhere in the genome (trans). In addition, for TMEM1,
multiple trans-eQTLs were identified (Fig. 3).
If the criteria are relaxed to a threshold of P , 0.001 (sug-
gestive linkage), eQTLs for eight additional genes are ident-
ified (last eight genes) (Table 2).
Figure 1. Normalized relative expression values for eight genes. Circles denote mean values for each of the 40 unrelated individuals, and bars indicate standard
error of the mean.
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Simulations
Variance component analysis is one of the most commonly
used model-free methods to perform quantitative linkage
analysis (24,25); however, it assumes that the traits analyzed
are normally distributed. Violations of normality by the
presence of outliers or excessive kurtosis can result in an
increased level of type 1 errors. (24,26,27) Many quantitative
traits are not normally distributed, for example, 84% of our
expression traits significantly deviate from normality. Ignoring
such deviations can lead to important misinterpretation of the
results (24).
One way to deal with the problem of non-normally distrib-
uted traits is to determine the empirical significance of the
linkage results (obtained through variance component or
regression methods) by performing simulation studies. To
this end, we computed 1000 simulations by randomizing the
genotypes but keeping the expression phenotypes constant.
Genotype randomization has the advantage of keeping herit-
ability patterns and other aspects of the data structure, such
as marker density, allele frequencies and missing data
unchanged.
We analyzed the results of the simulations by extracting the
highest linkage score per genome-scan per trait, in order to
build a significance distribution (the simulated maxium LOD
scores for each trait follow chi-square distributions). This
analysis showed that in nine out of 12 cases, the genes with sig-
nificant or suggestive eQTLs remained significant at the 95%
level (genes in bold, Table 2). Hence, a high proportion of
the eQTLs with suggestive P-values can be considered as sig-
nificant on a genomewide basis according to the simulations.
For some traits, the rates of type 1 errors were considerably
higher than expected (Fig. 3). For example, in the case of
TMEM1 where several trans-eQTLs were initially identified,
only one locus remained significant after adjustment.
As performing large-scale simulations is a computationally
intensive process, we assessed an alternative method
to address the problem of non-normality. We used Box–Cox
and bivariate-normal copula transformations in order to
approximate the traits distributions to normal. These trans-
formations have a minimal effect on the internal correlations
of the data. One thousand simulations were performed for
each transformed trait to determine the effect this would
have on the power and the rates of type 1 errors. Results of
these simulations showed that while the power was not
greatly affected by either type of data transformation (data
not shown), the effects on the levels of type 1 error were
variable and produced, at best, only small improvements
(Supplementary Material, Fig. S1). These results suggest that
data transformations are not efficient at solving the increased
rates of type 1 errors observed for some traits, and thus,
Table 1. Inter-individual gene expression variation
Gene Variance
ratio
Fold expression
difference
ITGB2 34.22 6.96
CBS 28.7 13.8
APP 24.32 47.43
PFKL 22.76 2.43
U2AF1 17.31 2.30
PRDM15 13.01 14.65
LSS 11.64 3.61
PDXK 9.81 2.77
SLC19A1 9.52 4.60
SLC37A1 8.96 3.90
PWP2H 7.34 2.0
MCM3AP 6.65 2.17
GART 6.28 2.56
CBR1 6.11 4.82
TMEM1 5.5 5.12
BTG3 5.4 3.23
DSCR1 5.23 3.36
ETS2 4.26 9.36
IFNAR2 3.97 2.34
ANKRD3 3.56 16.53
WRB 3.04 2.77
GABPA 2.14 2.54
SON 2.14 2.51
IFNAR1 1.99 2.51
CCT8 1.36 2.37
Figure 2. Heritabilities and associated P-values (expressed as 2log 10P) for
the 25 differentially expressed genes. Dotted line indicates 95% significance
threshold.
Table 2. Results of genomewide scan for gene expression traits
Gene eQTL(s) position SNP multipoint P-values
(Merlin)
TMEM1 12q24.33, 11q24.2,
4q26.2
7.463 1028, 4.24  1026,
2.47  1025
GART 6p25.1 1.663 1026
U2AF1 6p25.1 2.363 1025
CCT8 21q22.11 1.33 1024
PDXK 2q21.1 2.723 1024
SLC19A1 3q26.2 3.943 1024
GABPA 11p15.4 7.153 1024
PRDM15 15q13.2 7.523 1024
SLC37A1 19q13.42 9.423 1024
BTG3 12q21.32 4.08  1024
ETS2 12 4.46  1024
MCM3AP 4q26.1 8.74  1024
Values in bold are significant on a genomewide basis as determined by
simulation studies.
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simulations are highly advisable to properly assess the signifi-
cance of the results for each trait studied.
Association study
To further validate the cis-eQTL identified for the CCT8 gene,
we performed an association study using 60 additional
unrelated individuals from the CEPH collection for which
high-density genotyping data are available as part of the inter-
national HapMap project (28).
Gene expression variation was measured as before, and
genotypes for 41 SNPs from a 100 kb region surrounding
the CCT8 gene were obtained. We performed association
analysis for each SNP (predictor) to the normalized relative
CCT8 expression values (response) using analysis of variance
(ANOVA), and corrected for multiple tests using a step-down
approach (29). To guard against the effect of non-normal trait
distribution, we transformed the raw phenotypes to their logar-
ithmic values to yield a normally distributed trait (Shapiro test
for normality, P ¼ 0.56). Four SNPs were significantly associ-
ated with CCT8 expression levels (P ¼ 2.5  1025) even after
correction for multiple testing (P ¼ 9  1024). Out of these
SNPs, rs965951 is located in intron 14 of the gene, and
the three other SNPs (rs2832159, rs8133819, rs2832160) are
located 12 kb upstream. All four SNPs are in complete
linkage disequilibrium (r2 ¼ 1.0) (Fig. 4).
DISCUSSION
We set out to dissect the patterns of gene expression variation
on a 25 Mb segment of Hsa21, which has traditionally been
associated with many of the defining features of DS (mental
retardation, characteristic facies, muscle hypotonia) (20,30),
as well as with some of its variable phenotypes including con-
genital heart defects (31). In addition, this region of Hsa21 has
also been linked to some common complex disorders such as
bipolar affective disorder of unknown genetic etiology (32,33).
Our approach consisted in using real-time Taqman PCR and
multiple replicates per sample, as this has been shown to allow
the detection of small inter-individual differences in gene
expression (10) that might nonetheless be physiologically
important (34,35). Our data show that differences as small
Figure 3. Genomewide multipoint quantitative linkage plots. Dotted line indicates theoretical 95% significance threshold. Full line indicates empirical 95%
threshold as determined through simulations. Arrowheads indicate significant peaks.
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as 1.4-fold could be reliably measured, which compares
favorably to microarray procedures in which few replicates
per sample are performed, and for which typically only
changes .2-fold can be confidently detected (36).
Our results revealed a substantial amount of inter-individual
gene expression variation, as 25 out of the 41 genes analyzed
(61%) showed differential expression (based on our conserva-
tive criteria). This finding supports the notion that gene
expression variation is a highly important but poorly charac-
terized source of molecular diversity that is likely to explain
a considerable fraction of the phenotypic variance in the
population (37). The median fold change in expression level
between the lowest and highest values per gene among indi-
viduals was 3.2, with the largest inter-individual expression
differences observed for APP (Fig. 1). This is interesting, as
APP is crucially involved in the pathology of Alzheimer’s
disease, and different levels of APP could influence the patho-
genesis of this disorder.
DS is a disease caused by alterations in gene dosage such
that affected individuals are expected to have an average
Figure 4. Association of CCT8 expression levels to surrounding nucleotide variation. (A) 2log(P) versus SNP position for 100 kb surrounding CCT8 (41 SNPs
from HapMap data set). P-values shown were corrected for multiple hypothesis testing as described in Methods. Dotted line indicates nominally significant
(P, 0.05) results. Two regions of the locus comprising four SNPs are significant after correction. (B) Linkage disequilibrium between SNPs in selected
region as viewed with LD plot plugin (http://www.hapmap.org/cgi-perl/gbrowse/gbrowse/hapmap). Bright red regions are in complete LD (r2 ¼ 1.0). The
two groups of SNPs (four SNPs total) significantly correlated with CCT8 expression are circled. Dark lines point to squares representing complete LD
(r2 ¼ 1.0) between these sites.
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1.5-fold overexpression of Hsa21 genes (20). Given the exten-
sive variation in gene expression observed in our samples
among normal individuals (at least 2-fold), we would predict
that for many Hsa21 genes, there is a considerable overlap
in total expression levels between normal and trisomy 21 indi-
viduals due to allelic variation. Thus, expression variation at
the levels we report here may help to explain two related
aspects of DS phenotypes: penetrance and variability. Over-
expressed genes which have low levels of expression variation
would be predicted to lead to the more penetrant phenotypes
(e.g. CCT8 and U2AF1). In contrast, genes with high variation
in expression (e.g. ITGB2 and CBS) would contribute to incom-
pletely penetrant/variable DS-related phenotypes (model shown
in Supplementary Material, Fig. S2).
However, because the gene expression variation data
reported here are based on lymphoblastoid cell lines, confir-
mation of these results in additional cell types/tissues would
be of great interest.
Analysis of the segregation patterns of these ‘expression
traits’ in 10 CEPH pedigrees revealed that for 76% (19/25)
of genes, a significant fraction of the variation is explained
by genetic factors, with a median heritability of 0.42. Genome-
wide quantitative linkage analysis using previously generated
genotyping data (38) led to the identification of significant
eQTLs for nine out of the 19 genes, after correction for
biases in the data structure and for multiple testing. The large
majority of the eQTLs identified were in trans, suggesting
that quantitative or qualitative differences in certain genes
(transcription factors, proteins involved in signal transduction
and others) (18) have an impact on larger transcriptional net-
works. However, given the results of other studies showing
abundant allele-specific expression differences (39,40), we
expect cis-regulatory variation to be common and most likely
under-represented in our results.
For the CCT8 gene, which was the only one with a cis-
eQTL, we performed an association study to validate the
linkage findings. Results of the association analysis revealed
that a group of four SNPs within or close to CCT8 were sig-
nificantly associated with its expression levels, independently
confirming the presence of cis-regulatory variation.
An interesting finding is that for some genes with high
expression heritabilities (e.g. PWP2H and PFKL), no signifi-
cant eQTL was identified even though power calculations on
our sample size suggest 90% power to detect such loci.
We thus hypothesize that in many cases, expression traits
are regulated by multiple loci, each of which contributes
only modestly to the trait. This higher complexity in the
genetic architecture (41,42) underlying expression variation
indicates that only in cases in which few loci account for
a large proportion of the expression variability, eQTLs
will be identified effectively. This may explain the under-
representation of cis-eQTLs, and suggests that larger
sample sizes are required to dissect more complex genetic
regulation.
An important observation from our study is the increased
type 1 error for many of the expression traits when performing
variance components calculations for eQTL mapping. This
highlights the need to take appropriate measures, such as
simulations, to enable correct interpretation of the significance
of the results.
In two previous studies, QTL mapping of gene expression
traits was performed in humans using microarrays (17,43).
These studies have a higher throughput, with thousands of
genes being analyzed in parallel, which gives a more global
view of the genetic control of gene expression. However, for
specific regions involved in the etiology of human disorders,
such as the one presented here, a more focused study design
with higher number of replicates is possible, leading to a
more accurate estimation of individual expression levels.
In this study, we provide a detailed view of gene expression
variation of Hsa21 genes and a screen for eQTLs involved in
their regulation. The extensive expression variation observed
has important implications concerning the molecular patho-
genesis and phenotypic variability in DS patients. Large-
scale association studies with appropriate samples sizes will
constitute the next step for the identification of regulatory
variation.
MATERIALS AND METHODS
Families and lymphoblastoid cell culture
We obtained EBV-transformed lymphoblastoid cell lines of
135 individuals belonging to 10 CEPH (21) families (1333,
1334, 1340, 1341, 1345, 1346, 1347, 1362, 1408, 13292)
from Coriell cell repositories. All cell lines were grown in
RPMI 1640 with Glutamax I medium (Invitrogen Corporation)
supplemented with 10% fetal calf serum and 1% penicillin and
streptomycin mix (Invitrogen Corporation). Cells lines were
harvested at a density of 0.6–1  106 cells/ml and at least
80% viability. Cultures were spun for 5 min at 1000 g, and
the resulting pellets were washed once in PBS and lysed by
adding 2 ml of micro-glass beads (Sigma) and vortexing in
1 ml lysis solution containing b-mercaptoethanol (Qiagen,
RNeasy kit). Cell lysates were stored at 2808C.
RNAs were extracted using RNeasy mini kits with on-
column DNAse I digestion (Qiagen). RNA samples were
quantified by spectrophotometry, and the quality was assessed
using an Agilent 2100 BioAnalyzer with the RNA 6000 Nano
LabChip. All RNAs had a 260/280 nm ratio between 1.8–2,
and a 28s/18s rRNA ratio above 2.
cDNAs were synthesized from total RNA using SuperScriptII
reverse transcriptase (Invitrogen Corporation) and a poly d(T)
primer. For each cell line, 5 mg of total RNA in a total volume
of 20 ml were used, and the resulting cDNA was diluted 1:14
prior to PCR.
Gene selection and assay design
We chose to study a 25 Mb region of Hsa21 encompassing both
the so-called DS critical (30) region and the minimal region
thought to be involved in the development of the heart defect
phenotypes (atrial or ventricular septal defects or complete
atrioventricular canal) present in 40% of DS patients (31).
This region contains around 109 well-characterized genes.
On the basis of experimental data indicating expression in
lymphoblastoid cell lines (www.ensembl.org/Multi/martview?
species¼Homo_sapiens), we selected 71 genes for which
we designed Taqman assays. Assay designs are listed in
Supplementary Material, Table S1.
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Real-time quantitative PCR
Real-time quantitative PCR was carried out essentially as
described in Lyle et.al (10). Briefly, intron-spanning Taqman
assays were designed using PrimerExpress (Applied Biosys-
tems)with default parameters.Assay efficiencieswere calculated
using a cDNA dilution series (44). All PCRs were performed
using a qPCR mastermix (RT-QP2X-03, Eurogentec).
Reactions were set up using a Biomek 2000 robot
(Beckman), in a 10 ml volume in 384-well plates. Six repli-
cates per gene per sample were performed. PCRs were run
in an ABI 7900 Sequence Detection System (Applied Biosys-
tems) with the following conditions: 508C for 2 min, 958C for
10 min and 50 cycles of 958C 15 s/608C for 1 min.
To maximize the reproducibility of our results, we premixed
the required amount of cDNA, with a large volume of PCR
mastermix, to ensure uniformity in the starting concentration
of cDNA in all assays and replicates. In addition, the exper-
iment was designed so that all assays for a particular individ-
ual were run at the same time on a single plate, as this renders
the normalizations more accurate.
We checked that all CT-values were within the ranges tested
in assay efficiency tests. In addition, no systematic biases were
detected in the results as determined by assessing correlation
between the following variables: PCR efficiency (E), threshold
cycle (CT), relative expression and error (10).
qPCR data analysis
Raw cycle threshold (CT) values were obtained using SDS 2.0
software (Applied Biosystems). A threshold value of 0.2 was
used for all genes, and background was changed manually
for individual genes as recommended by Applied Biosystems.
From the six replicates per gene, outliers were detected using
Grubb’s test at the 95% significance level. For all calculations,
CT-values were converted to quantity (q) with the formula
q ¼ 22CT. Analyses were carried out in Excel, SPSS and
Minitab (MINITAB Inc.).
We normalized expression values by performing a median
normalization across all genes, excluding the 75th percentile
to minimize the effect of outliers. Each gene was then
median normalized across individuals. Normalized relative
expression values thus have a median of 1.
To determine which genes show significant levels of
expression variation in our cohort, we measured expression
levels in a group of 40 unrelated individuals. We evaluated
the levels of gene expression variation by means of the variance
ratio obtained by dividing the inter-individual variance of the
means of each gene by the mean intra-individual error. We
selected 25 genes which had a variance ratio above 1.3.
Heritability, linkage, simulations and association
Heritability calculations were performed using the ‘polygenic-
screen’ command from the SOLAR software (45). To calcu-
late the empirical significance of the heritability values, we
performed a multiple permutation test in which the phenotypic
values for all traits were randomly permuted 500 times and
heritabilities calculated as before. These results were used to
determine the 95% significance thresholds.
SNP genotyping data, consisting of 2688 autosomal SNPs
with an effective resolution of 3.9 cM, were downloaded
from the SNP Consortium database (http://snp.cshl.org/
linkage_maps/) (38). Multipoint linkage with the SNP map
was performed using Merlin (46) with the –VC option, after
Mendelian inconsistencies (PEDCHECK) (22) and unlikely
genotypes (PEDWIPE) (46) were removed.
To calculate the empirical significance of the linkage
results, we performed 1000 simulations for each quantitative
trait using the –simulate command from Merlin with different
seed numbers. We extracted the highest result from each simu-
lation to build significance distributions. The distribution of
the maximum scores of permutations followed a chi-squared
distribution.
To evaluate the effect of non-normality on the power and
levels of type 1 errors in our data, we transformed all traits
by: (i) Box–Cox transformation using Minitab, (ii) the bivari-
ate normal copula as described by Basrak et al. (27). We per-
formed 1000 simulations for each transformed trait and built
significance distributions as described above. All simulations
were performed using a cluster of 32 HP/Intel Itanium 2
based servers at the Vital-IT Center.
Association of CCT8 expression and cis-nucleotide variation
was done using anovasnp (version 0.7) (D. Posada, manuscript
in preparation) with 100 000 permutations to correct for mul-
tiple hypotheses using a step-down procedure (29). Genotypes
were downloaded from the HapMap project URL (http://
www.hapmap.org/cgi-perl/gbrowse/gbrowse/hapmap),
HapMap public release no. 16c.1.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online.
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